Exane Derivatives’s Signature Bank SBNY Stock Holding History

Exane Derivatives's SBNY Position: Q2 2022 in Review

Exane Derivatives reduced its Signature Bank (SBNY) stake by 72% in Q2 2022, selling an estimated $273K and leaving 465 shares worth $83.3K. The position accounts for 0.05% of the portfolio, ranked #281.

Exane Derivatives first reported a position in SBNY in Q4 2015 and has held it in 8 quarters since. The position peaked at $768K in Q4 2021. 546 funds tracked by Wall St. Rank hold SBNY as of Q2 2022.

• Exane Derivatives held 465 shares of Signature Bank worth $83.3K as of Q2 2022.
• Exane Derivatives sold 1,220 Signature Bank shares in Q2 2022, an estimated $273K.
• Signature Bank made up 0.05% of Exane Derivatives's portfolio in Q2 2022, its #281 holding.
• Exane Derivatives first reported a position in Signature Bank in Q4 2015 and has held it in 8 quarters since.
• Exane Derivatives's Signature Bank position peaked at $768K in Q4 2021.
• 546 funds tracked by Wall St. Rank held Signature Bank as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.